CVR: 40560866
Aesculus Bio ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2019. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Benjamin Anderschou Holbech Jensen. The company is owned by Benjamin Anderschou Holbech Jensen, PN INVESTMENT ApS and Jan Wehkamp. In 2025, the company reported a gross profit of DKK -154,862 and a net result of DKK -129,437 compared with DKK -45,866 the year before. Equity amounted to DKK -34,097.
Your company? Claim the profile and show your logo, website and social channels — for free.
Claim this profileSelskabets formål er at drive forskning og udvikling rettet mod udvikling af medicinske produkter, som kan regulere microbiota og dermed relaterede sygdomme, og andre hermed relaterede aktiviteter.
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreScreen owners and management against the Danish FSA's official PEP lists
Aesculus Bio ApS has published its annual report for 2025. Gross profit came to DKK -154,862, and the net result was DKK -129,437.
Aesculus Bio ApS has published its annual report for 2024. Gross profit came to DKK -49,785, and the net result was DKK -45,866.
Aesculus Bio ApS has published its annual report for 2023. Gross profit came to DKK -13,631, and the net result was DKK -10,881.
Aesculus Bio ApS has published its annual report for 2022. Gross profit came to DKK -25,019, and the net result was DKK -14,524.
As of September 8, 2022, Benjamin Anderschou Holbech Jensen is registered as an owner of Aesculus Bio ApS with an ownership share of 15%.
Aesculus Bio ApS has published its annual report for 2021. Gross profit came to DKK 87,677, and the net result was DKK 73,545.
Aesculus Bio ApS has published its annual report for 2020. Gross profit came to DKK -11,740, and the net result was DKK -14,631.
Aesculus Bio ApS has published its interim report for the period May 14, 2019 – December 31, 2019.
As of April 18, 2020, PN INVESTMENT ApS is registered as an owner of Aesculus Bio ApS with an ownership share of 33%.
As of May 14, 2019, Benjamin Anderschou Holbech Jensen has joined the board of directors of Aesculus Bio ApS.
As of May 14, 2019, Peter Hviid Nordkild has joined the board of directors of Aesculus Bio ApS.
As of May 14, 2019, Benjamin Anderschou Holbech Jensen is registered as adm. dir. of Aesculus Bio ApS.
As of May 14, 2019, is registered as an owner of Aesculus Bio ApS with an ownership share of 33%.
Aesculus Bio ApS was founded on May 14, 2019.
Companies in the same industry and area
CVR 29418888
CVR 29769796
CVR 34688605
CVR 34892970
CVR 35047565